Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,016 | 270 | 98.4% |
| Education | $116.30 | 5 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,589 | 67 | $0 (2024) |
| Novo Nordisk Inc | $947.74 | 40 | $0 (2024) |
| Lilly USA, LLC | $837.30 | 29 | $0 (2024) |
| Amarin Pharma Inc. | $817.15 | 32 | $0 (2022) |
| Merck Sharp & Dohme LLC | $575.20 | 33 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $484.27 | 18 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $425.60 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $397.53 | 14 | $0 (2021) |
| Amgen Inc. | $387.13 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $155.81 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,422 | 38 | Amgen Inc. ($363.62) |
| 2023 | $452.75 | 18 | Novo Nordisk Inc ($238.06) |
| 2022 | $303.83 | 11 | Novo Nordisk Inc ($140.76) |
| 2021 | $338.99 | 14 | Lilly USA, LLC ($113.90) |
| 2020 | $1,406 | 54 | Amarin Pharma Inc. ($620.89) |
| 2019 | $864.49 | 44 | AstraZeneca Pharmaceuticals LP ($310.05) |
| 2018 | $1,301 | 49 | AstraZeneca Pharmaceuticals LP ($458.33) |
| 2017 | $1,043 | 47 | AstraZeneca Pharmaceuticals LP ($218.68) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Oncology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: DIABETES | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Inflammation | ||||||
| 06/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Diabetes | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Oncology | ||||||
| 05/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Inflammation | ||||||
| 04/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRADJENTA | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 311 | 422 | $47,874 | $21,501 |
| 2022 | 12 | 329 | 428 | $47,076 | $23,636 |
| 2021 | 7 | 281 | 364 | $44,210 | $24,229 |
| 2020 | 9 | 264 | 353 | $39,170 | $23,675 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 103 | $23,150 | $8,769 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 42 | 42 | $9,450 | $6,257 | 66.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 37 | $5,550 | $2,616 | 47.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 30 | $1,709 | $1,079 | 63.2% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 54 | 74 | $3,330 | $985.26 | 29.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 24 | 25 | $1,105 | $543.45 | 49.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 15 | 18 | $1,056 | $296.28 | 28.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 16 | 22 | $858.00 | $288.64 | 33.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 17 | 25 | $725.00 | $258.75 | 35.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 27 | $389.88 | $226.80 | 58.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 19 | $551.00 | $180.88 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 116 | $23,700 | $10,967 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 44 | 44 | $10,625 | $6,774 | 63.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 33 | $4,950 | $2,207 | 44.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 31 | $1,582 | $1,095 | 69.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 29 | 32 | $1,325 | $672.79 | 50.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 14 | $575.00 | $495.50 | 86.2% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2022 | 25 | 26 | $870.00 | $361.85 | 41.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 12 | 19 | $741.00 | $250.80 | 33.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 12 | 15 | $880.20 | $248.26 | 28.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 13 | 20 | $580.00 | $208.12 | 35.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 19 | $551.00 | $181.89 | 33.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 48 | 59 | $696.56 | $174.69 | 25.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 127 | $25,100 | $12,464 | 49.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 48 | 48 | $11,900 | $7,598 | 63.8% |
About Dr. Clifford Young, M.D
Dr. Clifford Young, M.D is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437161114.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clifford Young, M.D has received a total of $7,132 in payments from pharmaceutical and medical device companies, with $1,422 received in 2024. These payments were reported across 275 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($7,016).
As a Medicare-enrolled provider, Young has provided services to 1,185 Medicare beneficiaries, totaling 1,567 services with total Medicare billing of $93,041. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Brooklyn, NY
- Active Since 08/12/2006
- Last Updated 05/09/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437161114
Products in Payments
- FARXIGA (Drug) $1,272
- Vascepa (Drug) $817.15
- JANUVIA (Drug) $513.07
- JARDIANCE (Drug) $432.42
- TRULICITY (Drug) $373.23
- Ozempic (Drug) $327.36
- MOUNJARO (Drug) $265.99
- Otezla (Drug) $262.13
- INVOKANA (Drug) $247.05
- Rybelsus (Drug) $236.55
- SOLIQUA (Drug) $204.54
- Wegovy (Drug) $157.92
- XARELTO (Drug) $150.48
- Cologuard Collection Kit (Device) $144.94
- TOUJEO (Drug) $143.19
- ENTRESTO (Drug) $142.07
- AIRSUPRA (Drug) $135.00
- Repatha (Biological) $125.00
- SYMBICORT (Drug) $124.26
- Saxenda (Drug) $90.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733